首页> 外国专利> Mirtazapine solution or suspension mixed with water, pharmaceutical formulation comprising mirtazapine, and use of mirtazapine

Mirtazapine solution or suspension mixed with water, pharmaceutical formulation comprising mirtazapine, and use of mirtazapine

机译:米氮平溶液或混悬液与水混合,包含米氮平的药物制剂,以及米氮平的用途

摘要

"MIRTAZAPINE SOLUTION OR SUSPENSION IN MIXTURE WITH WATER, PHARMACEUTICAL FORMULATION UNDERSTANDING MIRTAZAPINE, AND, USE OF MIRTAZAPINE" A solution or an aqueous suspension for the oral administration of the antidepressant mirtazapine which is preferably stabilized by methionine, is thickened and is thickened. a pH of 2.5 to 3. By the formulation according to the invention, an undesirable local anesthetic effect of mirtazapine is avoided.
机译:“与水混合的米氮他平溶液或悬浮液,理解米氮他平的药物制剂,以及使用米氮他滨”用于口服给药抗抑郁药米氮氮平的溶液或水悬浮液应增稠并增稠,最好是用蛋氨酸稳定。 pH为2.5至3。通过本发明的制剂,避免了米氮平的不希望的局部麻醉作用。

著录项

  • 公开/公告号BR9909357A

    专利类型

  • 公开/公告日2000-12-12

    原文格式PDF

  • 申请/专利权人 AKZO NOBEL N.V;

    申请/专利号BR19999909357

  • 申请日1999-03-29

  • 分类号A61K31/495;A61K9/08;

  • 国家 BR

  • 入库时间 2022-08-22 01:26:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号